{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T11:43:10Z","timestamp":1789818190503,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Wellcome Trust"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.biologicals.2020.06.005","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T07:58:35Z","timestamp":1592899115000},"page":"35-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["SARS-CoV-2: Virology, epidemiology, immunology and vaccine development"],"prefix":"10.1016","volume":"66","author":[{"given":"Marc","family":"Baay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Lina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Fontanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Marchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Saville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Sabot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Duclos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris","family":"Vandeputte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Neels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2020.06.005_bib1","series-title":"Estimating the burden of SARS-CoV-2 in France","author":"Salje","year":"2020"},{"issue":"6","key":"10.1016\/j.biologicals.2020.06.005_bib2","doi-asserted-by":"crossref","first-page":"E1871","DOI":"10.3390\/jcm9061871","article-title":"Performance assessment of SARS-CoV-2 PCR assays developed by WHO referral laboratories","volume":"9","author":"Etievvant","year":"2020","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.biologicals.2020.06.005_bib3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1473-3099(20)30200-0","article-title":"Clinical and virological data of the first cases of COVID-19 in Europe: a case series","volume":"20","author":"Lescure","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.biologicals.2020.06.005_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.04.029","article-title":"Type I IFN immunoprofiling in COVID-19 patients","author":"Trouillet-Assant","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.biologicals.2020.06.005_bib5","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biologicals.2020.06.005_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/infdis\/jiaa161","article-title":"Coronavirus occurrence and transmission over 8 years in the HIVE cohort of households in Michigan","volume":"222","author":"Monto","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.biologicals.2020.06.005_bib7","author":"World Health Organization"},{"key":"10.1016\/j.biologicals.2020.06.005_bib8","author":"World Health Organization"},{"key":"10.1016\/j.biologicals.2020.06.005_bib9","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/S2666-5247(20)30003-3","article-title":"Stability of SARS-CoV-2 in different environmental conditions","volume":"1","author":"Chin","year":"2020","journal-title":"Lancet Microb."},{"key":"10.1016\/j.biologicals.2020.06.005_bib10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1086\/524065","article-title":"Epidemiologic characterization of the 1918 influenza pandemic summer wave in Copenhagen: implications for pandemic control strategies","volume":"197","author":"Andreasen","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.biologicals.2020.06.005_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102429","article-title":"Demonstrating the use of high-volume electronic medical claims data to monitor local and regional influenza activity in the US","volume":"9","author":"Viboud","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.biologicals.2020.06.005_bib12","doi-asserted-by":"crossref","first-page":"13422","DOI":"10.1073\/pnas.1303117110","article-title":"Increased transmissibility explains the third wave of infection by the 2009 H1N1 pandemic virus in England","volume":"110","author":"Dorigatti","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biologicals.2020.06.005_bib13","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","author":"Ackermann","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biologicals.2020.06.005_bib14","first-page":"1","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.biologicals.2020.06.005_bib15","first-page":"1","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","author":"Merad","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.biologicals.2020.06.005_bib16","series-title":"Immunology of COVID-19: current state of the science","author":"Vabret","year":"2020"},{"key":"10.1016\/j.biologicals.2020.06.005_bib17","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001439","article-title":"The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection","author":"Kellam","year":"2020","journal-title":"J Gen Virol"},{"key":"10.1016\/j.biologicals.2020.06.005_bib18","first-page":"2020","article-title":"Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study","author":"Miller","year":"2020","journal-title":"medRxiv"},{"issue":"22","key":"10.1016\/j.biologicals.2020.06.005_bib19","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.2020.8189","article-title":"SARS-CoV-2 rates in BCG-vaccinated and unvaccinated young adults","volume":"323","author":"Hamiel","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.biologicals.2020.06.005_bib21","first-page":"85","volume":"vol. 61","author":"Baay","year":"2019"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104510562030066X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104510562030066X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:14:08Z","timestamp":1760922848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104510562030066X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":20,"alternative-id":["S104510562030066X"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2020.06.005","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2: Virology, epidemiology, immunology and vaccine development","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2020.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization.","name":"copyright","label":"Copyright"}]}}